Immediate Impact

35 standout
Sub-graph 1 of 18

Citing Papers

Acute graft-versus-host disease
2023 Standout
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
2022 Standout
5 intermediate papers

Works of Anne Hunter being referenced

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
2004

Author Peers

Author Last Decade Papers Cites
Anne Hunter 132 138 10 128 3 245
Silja Mack 49 157 20 62 6 257
Karl‐Walter Sykora 72 155 20 49 5 275
J.J. Luan 203 55 9 185 6 251
S. von Harsdorf 39 100 23 50 5 237
Angela Bowen 95 133 44 33 7 299
Scott VanWier 41 204 9 71 4 270
Isabelle Dervite 133 74 14 128 3 274
E. Jamieson 38 117 8 80 5 161
M. Maynadié 129 45 15 58 6 227
Cristina Barrenetxea 19 199 8 107 6 283

All Works

Loading papers...

Rankless by CCL
2026